<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00524732</url>
  </required_header>
  <id_info>
    <org_study_id>TD511</org_study_id>
    <nct_id>NCT00524732</nct_id>
  </id_info>
  <brief_title>Assessment of the Reactogenicity of ADACEL® (TdcP Vaccine) in Children and Adolescents 7 to 19 Years of Age</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sanofi Pasteur, a Sanofi Company</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sanofi</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To compare the reactogenicity of ADACEL® vaccine given at intervals of 2 to 9 years with the
      reactogenicity of ADACEL® vaccine given at an interval of 10 or more years following the last
      previous administration of vaccine containing Diphtheria and Tetanus Toxoids (referred to as
      TD/Td).
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2004</start_date>
  <completion_date type="Actual">September 2005</completion_date>
  <primary_completion_date type="Actual">December 2004</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>To provide safety information on ADACEL® vaccine given at different time intervals.</measure>
    <time_frame>Up to 114 months post-vaccination</time_frame>
  </primary_outcome>
  <number_of_groups>9</number_of_groups>
  <enrollment type="Actual">7156</enrollment>
  <condition>Pertussis</condition>
  <condition>Diphtheria</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <description>18 to 30 months since last prior dose of TD/Td vaccine.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <description>30 to 42 months since last prior dose of TD/Td vaccine.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3</arm_group_label>
    <description>42 to 54 months since last prior dose of TD/Td vaccine.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>4</arm_group_label>
    <description>54 to 66 months since last prior dose of TD/Td vaccine.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>5</arm_group_label>
    <description>66 to 78 months since last prior dose of TD/Td vaccine.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>6</arm_group_label>
    <description>78 to 90 months since last prior dose of TD/Td vaccine.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>7</arm_group_label>
    <description>90 to 102 months since last prior dose of TD/Td vaccine.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>8</arm_group_label>
    <description>102 to 114 months since last prior dose of TD/Td vaccine.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>9</arm_group_label>
    <description>Control - over 114 months since last prior dose of TD/Td vaccine.</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Tetanus and diphtheria toxoids and acellular pertussis</intervention_name>
    <description>0.5 mL, Intramuscular</description>
    <arm_group_label>1</arm_group_label>
    <arm_group_label>2</arm_group_label>
    <arm_group_label>3</arm_group_label>
    <arm_group_label>4</arm_group_label>
    <arm_group_label>5</arm_group_label>
    <arm_group_label>6</arm_group_label>
    <arm_group_label>7</arm_group_label>
    <arm_group_label>8</arm_group_label>
    <arm_group_label>9</arm_group_label>
    <other_name>ADACEL®</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Children and Adolescents 7 to 19 Years of Age, who have previously recieved Tetanus and
        Diphtheria Toxoids Vaccine
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age &gt; 7 years and &lt; 20 years.

          -  Signed and dated IRB-approved informed consent form obtained from the participant,
             parent or legal guardian prior to the first study intervention.

          -  Judged to be in good health on the basis of reported medical history.

          -  Available for planned length of the study.

          -  Participant or parent or legal guardian (as applicable) can read and write English and
             can understand the informed consent documents and the study instructions.

        A participant eleven years of age or older who meets an exclusion criterion may not be
        enrolled in the study but nonetheless may participate in the vaccination program, at the
        discretion of the Prince Edward Island public health authorities).

        A participant younger than eleven years of age who meets an exclusion criterion may not be
        enrolled in the study and may not participate in the vaccination program.

        Exclusion Criteria:

          -  Known or suspected allergy to ADACEL®, any of the vaccine's components, or prior
             allergic reaction to Diphtheria or Tetanus Toxoids or Acellular Pertussis Vaccine.

          -  Planned receipt of any other vaccine within the 14 days following administration of
             ADACEL® vaccine in this study.

          -  Any other medical condition that in the opinion of the investigator would cause an
             unexpected hazard or interfere with the study objective.

          -  Receipt of TD/Td within the preceding 12 months.

          -  Known or suspected to be pregnant.

        A participant eleven years of age or older who meets an exclusion criterion may not be
        enrolled in the study but nonetheless may participate in the vaccination program, at the
        discretion of the Prince Edward Island public health authorities).

        A participant younger than eleven years of age who meets an exclusion criterion may not be
        enrolled in the study and may not participate in the vaccination program.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>7 Years</minimum_age>
    <maximum_age>19 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Medical Director</last_name>
    <role>Study Director</role>
    <affiliation>Sanofi Pasteur Inc.</affiliation>
  </overall_official>
  <location>
    <facility>
      <address>
        <city>Halifax</city>
        <state>Nova Scotia</state>
        <zip>NS B3K 6R8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Charlottetown</city>
        <zip>C1A 7N8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <link>
    <url>http://www.sanofipasteur.com</url>
  </link>
  <link>
    <url>http://www.sanofi.com</url>
  </link>
  <results_reference>
    <citation>Halperin SA, Sweet L, Baxendale D, Neatby A, Rykers P, Smith B, Zelman M, Maus D, Lavigne P, Decker MD. How soon after a prior tetanus-diphtheria vaccination can one give adult formulation tetanus-diphtheria-acellular pertussis vaccine? Pediatr Infect Dis J. 2006 Mar;25(3):195-200.</citation>
    <PMID>16511379</PMID>
  </results_reference>
  <verification_date>January 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 4, 2007</study_first_submitted>
  <study_first_submitted_qc>September 4, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 5, 2007</study_first_posted>
  <last_update_submitted>January 10, 2014</last_update_submitted>
  <last_update_submitted_qc>January 10, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 14, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Pertussis</keyword>
  <keyword>Tetanus</keyword>
  <keyword>Diphtheria</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Whooping Cough</mesh_term>
    <mesh_term>Diphtheria</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vaccines</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

